You just read:

Presentations at ID Week™ 2017 Highlight Clinical Results and Microbiome Analysis of Patients Treated in Rebiotix's RBX2660 Phase 2 Studies

News provided by

Rebiotix Inc.

Oct 04, 2017, 08:01 ET